When patients are unable to express their wishes and do not have surrogates or advance directives, which and whose values should inform decision making for them? We discuss ethical complexities of caring for unrepresented patients.
Labels commonly used in clinical settings, like “elective” or “therapeutic,” influence how we think about the justifiability of abortion. We talk with Professor Katie Watson and Dr Maryl Sackeim about how the language clinicians use to describe abortion can affect patients’ experiences and even cause harm.
Professor Katie Watson joins Ethics Talk to discuss what clinicians need to know about changes to the post-June 2022 legal, ethical, and clinical landscape of abortion care in the US.
Professor Michele Bratcher Goodwin joins Ethics Talk to consider how members of different US Supreme Courts have interpreted the US Constitution in ways that have supported or undermined liberty in surprising ways.
Conflicts of interest must be acknowledged with sincerity and earnestness and managed such that the conflict is eliminated or, at least, credibly mitigated.
AMA J Ethics. 2023;25(3):E186-193. doi:
10.1001/amajethics.2023.186.
This commentary on a case considers a transgender patient’s mental health and risk for DVT in ethical decision making about feminizing gender-affirming hormone therapy.
AMA J Ethics. 2023;25(6):E386-390. doi:
10.1001/amajethics.2023.386.